Healthcare
•3762 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3762)
| Company | Market Cap | Price |
|---|---|---|
|
PASG
Passage Bio, Inc.
PBFT02 is Passage Bio's lead gene therapy program directly developed by the company.
|
$23.86M |
$7.51
-2.15%
|
|
XFOR
X4 Pharmaceuticals, Inc.
Company develops therapies targeting rare immune disorders (WHIM syndrome, CN), fitting Biotech - Rare Diseases.
|
$23.39M |
$4.04
+0.12%
|
|
NXPL
NextPlat Corp
Management is pivoting toward higher-margin healthcare services and 340B contracts, a Healthcare Services & Facilities focus.
|
$23.37M |
$0.88
-1.76%
|
|
COSM
Cosmos Health Inc.
Owns/operates in-house EU GMP manufacturing via Cana Laboratories Holdings Cyprus Ltd. and Cana S.A., enabling contract manufacturing revenue.
|
$23.29M |
$0.78
-3.84%
|
|
ENLV
Enlivex Therapeutics Ltd.
Allocetra is Enlivex's lead cell therapy platform, directly produced and administered as a therapeutic cell product.
|
$23.09M |
$1.05
|
|
MGRX
Mangoceuticals, Inc.
Patented antiviral small-molecule therapeutics (MGX-0024) introduced as an IP asset with clinical development.
|
$22.95M |
$1.90
-8.89%
|
|
HBIO
Harvard Bioscience, Inc.
HBIO generates recurring revenue from consumables used with its medical devices and bioproduction platforms (biochips, reagents, etc.).
|
$22.84M |
$0.56
+9.16%
|
|
CASI
CASI Pharmaceuticals, Inc.
CID-103 is a monoclonal antibody therapeutic, a core product class for the company.
|
$22.02M |
$1.38
-4.17%
|
|
ALLR
Allarity Therapeutics, Inc.
Allarity is a clinical-stage biotech focused on oncology therapies (stenoparib) and cancer drug development.
|
$21.87M |
$1.39
-4.48%
|
|
GTHP
Guided Therapeutics, Inc.
LuViva is a point-of-care diagnostic device used for cervical cancer screening, which aligns with Diagnostic Equipment.
|
$21.68M |
$0.27
|
|
CVM
CEL-SCI Corporation
Direct product category for CEL-SCI's lead immunotherapy for cancer (Multikine) under oncology biotech.
|
$21.52M |
$7.15
+0.85%
|
|
STCB
Starco Brands, Inc.
Vertical integration via acquisition of The Starco Group provides contract manufacturing capabilities.
|
$21.17M |
$0.03
|
|
PETV
PetVivo Holdings, Inc.
PetVivo's Spryng is a veterinarian-administered medical device/biomaterial for osteoarthritis in dogs and horses.
|
$21.12M |
$1.46
|
|
CLSD
Clearside Biomedical, Inc.
Clearside's core offering is a drug delivery platform enabling suprachoroidal (eye) delivery and extended-release formulations.
|
$21.08M |
$4.02
-1.23%
|
|
CDIX
Cardiff Lexington Corporation
Nova Ortho & Spine provides diagnostic and related assessment services, aligning with Diagnostics & Lab Services in Healthcare.
|
$19.88M |
$1.01
|
|
SYBX
Synlogic, Inc.
PKU is a rare metabolic disease and Synlogic's lead programs target rare diseases via a synthetic biology platform.
|
$19.77M |
$1.70
+0.59%
|
|
NRXS
NeurAxis, Inc.
Core product line: Neuromodulation devices (IB-Stim PENFS).
|
$19.63M |
$2.74
+0.74%
|
|
ACUT
Accustem Sciences Inc.
Company plans to offer Laboratory Testing & Advisory Services leveraging existing lab infrastructure and additional sequencing/heritage panels.
|
$19.45M |
$1.21
|
|
KAPA
Kairos Pharma, Ltd.
Kairos Pharma is a clinical-stage biopharma focused on oncology therapies, including immunotherapies and cell therapies.
|
$19.04M |
$1.03
-8.41%
|
|
NXGL
NEXGEL, Inc.
NXGEL generates revenue from contract manufacturing of hydrogel-based medical and consumer products.
|
$18.83M |
$2.38
-3.05%
|
|
HOTH
Hoth Therapeutics, Inc.
HT-001 (oncology supportive care) and HT-KIT/HT-ALZ pipelines place Hoth in oncology/biotech with a focused cancer therapy strategy.
|
$18.76M |
$1.40
-1.41%
|
|
TOMZ
TOMI Environmental Solutions, Inc.
Product category aligns with healthcare-themed medical devices and equipment, including disinfection hardware (SteraMist SIS/CES).
|
$18.63M |
$0.91
-1.87%
|
|
LPTX
Leap Therapeutics, Inc.
Leap Therapeutics is a biotech company focused on oncology therapies, with lead assets in antibody-based cancer treatments.
|
$18.53M |
$0.41
-7.85%
|
|
PYPD
PolyPid Ltd.
D-PLEX100 leverages PolyPid's PLEX drug-delivery platform to provide localized, prolonged antibiotic release at the surgical site.
|
$18.37M |
$3.81
-0.65%
|
|
ELTP
Elite Pharmaceuticals, Inc.
Elite focuses on the development, manufacture, and sale of generic drugs across a broad pipeline.
|
$18.04M |
$0.61
|
|
PULM
Pulmatrix, Inc.
Pulmatrix's core offering is the iSPERSE dry powder drug delivery platform, a direct product category.
|
$18.01M |
$4.84
-1.72%
|
|
LEXX
Lexaria Bioscience Corp.
Lexaria's DehydraTECH is a proprietary drug delivery platform that enhances API absorption and enables oral formulations.
|
$17.91M |
$1.02
+0.49%
|
|
IRIX
IRIDEX Corporation
IRIDEX directly designs, manufactures and sells ophthalmology devices (laser platforms, delivery systems) for eye diseases.
|
$17.63M |
$1.04
-0.48%
|
|
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
MEDIFLY maggot debridement therapy is Cuprina's flagship wound care device/product.
|
$17.61M |
$0.94
-4.36%
|
|
ADGM
Adagio Medical Holdings, Inc.
ADGM is a medical technology company whose core offerings are medical devices/biometrics for cardiac ablation.
|
$17.53M |
$1.13
-0.88%
|
|
FEMY
Femasys Inc.
Femasys manufactures medical devices and biometrics for women's reproductive health (FemBloc, FemaSeed, FemVue, etc.).
|
$17.35M |
$0.62
-3.01%
|
|
DARE
Daré Bioscience, Inc.
Drug Delivery Platforms: Daré's core IDDS platform is used to deliver hormones and contraceptive agents (e.g., DARE-LARC1) and supports multiple pipeline programs, making this a primary product/technology category.
|
$17.35M |
$1.93
-1.79%
|
|
LIPO
Lipella Pharmaceuticals Inc.
Lipella's core metastable liposome drug delivery platform enables targeted, localized mucosal drug formulations.
|
$17.17M |
$0.43
|
|
COCH
Envoy Medical, Inc.
Envoy Medical designs and manufactures implantable medical devices with biometric sensing capabilities (Acclaim CI and Esteem FI-AMEI).
|
$17.17M |
$0.75
-6.75%
|
|
NAII
Natural Alternatives International, Inc.
Direct contract manufacturing services for private-label vitamins, minerals, herbal and other health care products.
|
$16.84M |
$2.82
+3.49%
|
Showing page 32 of 38 (3762 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
